Cyclophosphamide-induced hepatotoxicity in a patient with Wegener's granulomatosis.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 8246624.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cyclophosphamide is widely used in the treatment of many vasculitides. Hepatotoxicity associated with such therapy is uncommon but possible. Herein we describe a well-substantiated case of cyclophosphamide-induced hepatotoxicity in a patient with Wegener's granulomatosis. Physicians should be aware of this potentially serious reaction when cyclophosphamide therapy is initiated. Baseline liver function tests and periodic assessment are recommended during treatment with cyclophosphamide.
Medical subject headings
- Chemical and Drug Induced Liver Injury
- Cyclophosphamide
- Granulomatosis with Polyangiitis